Search Results - "Brodie, R R"

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study by Stone, Gregg W, Dr, Witzenbichler, Bernhard, MD, Weisz, Giora, MD, Rinaldi, Michael J, MD, Neumann, Franz-Josef, MD, Metzger, D Christopher, MD, Henry, Timothy D, MD, Cox, David A, MD, Duffy, Peter L, MD, Mazzaferri, Ernest, MD, Gurbel, Paul A, MD, Xu, Ke, PhD, Parise, Helen, MSc, Kirtane, Ajay J, MD, Brodie, Bruce R, MD, Mehran, Roxana, MD, Stuckey, Thomas D, MD

“…Summary Background The relation between platelet reactivity and stent thrombosis, major bleeding, and other adverse events after coronary artery implantation…”
Get full text

Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy by Narula, Amar, Mehran, Roxana, Weisz, Giora, Dangas, George D, Yu, Jennifer, Généreux, Philippe, Nikolsky, Eugenia, Brener, Sorin J, Witzenbichler, Bernhard, Guagliumi, Giulio, Clark, Avery E, Fahy, Martin, Xu, Ke, Brodie, Bruce R, Stone, Gregg W

“…We sought to examine the short- and long-term outcomes of patients who developed contrast-induced acute kidney injury (CI-AKI; defined as an increase in serum…”
Get full text

Geodesics in the extended Kähler cone of Calabi-Yau threefolds by Brodie, Callum R., Constantin, Andrei, Lukas, Andre, Ruehle, Fabian

“…A bstract We present a detailed study of the effective cones of Calabi-Yau threefolds with h 1 , 1 = 2, including the possible types of walls bounding the…”
Get full text

Heterotic line bundle models on elliptically fibered Calabi-Yau three-folds by Braun, Andreas P., Brodie, Callum R., Lukas, Andre

“…A bstract We analyze heterotic line bundle models on elliptically fibered Calabi-Yau three-folds over weak Fano bases. In order to facilitate Wilson line…”
Get full text

Sex-based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: Three year results from the HORIZONS-AMI trial by Yu, Jennifer, Mehran, Roxana, Grinfeld, Liliana, Xu, Ke, Nikolsky, Eugenia, Brodie, Bruce R., Witzenbichler, Bernhard, Kornowski, Ran, Dangas, George D., Lansky, Alexandra J., Stone, Gregg W.

“…Background Studies have shown sex‐based disparities in ST‐segment elevation myocardial infarction (STEMI) management and prognosis. We sought to compare women…”
Get full text

Near-perfect broadband absorption from hyperbolic metamaterial nanoparticles by Riley, Conor T., Smalley, Joseph S. T., Brodie, Jeffrey R. J., Fainman, Yeshaiahu, Sirbuly, Donald J., Liu, Zhaowei

“…Broadband absorbers are essential components of many light detection, energy harvesting, and camouflage schemes. Current designs are either bulky or use planar…”
Get full text

Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction by Dangas, George D, Caixeta, Adriano, Mehran, Roxana, Parise, Helen, Lansky, Alexandra J, Cristea, Ecaterina, Brodie, Bruce R, Witzenbichler, Bernhard, Guagliumi, Giulio, Peruga, Jan Z, Dudek, Dariusz, Möeckel, Martin, Stone, Gregg W

“…Concerns persist regarding the risk of stent thrombosis in the setting of primary percutaneous coronary intervention for ST-segment elevation myocardial…”
Get full text

Paclitaxel-Eluting Stents versus Bare-Metal Stents in Acute Myocardial Infarction by Stone, Gregg W, Lansky, Alexandra J, Pocock, Stuart J, Gersh, Bernard J, Dangas, George, Wong, S. Chiu, Witzenbichler, Bernhard, Guagliumi, Giulio, Peruga, Jan Z, Brodie, Bruce R, Dudek, Dariusz, Möckel, Martin, Ochala, Andrzej, Kellock, Alison, Parise, Helen, Mehran, Roxana

“…Acute ST-segment elevation myocardial infarction is often treated with immediate coronary stenting of the infarct-related artery. The use of a…”
Get full text

Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial by Stone, Gregg W, Dr, Prof, Witzenbichler, Bernhard, MD, Guagliumi, Giulio, MD, Peruga, Jan Z, MD, Brodie, Bruce R, MD, Dudek, Dariusz, MD, Kornowski, Ran, MD, Hartmann, Franz, MD, Gersh, Bernard J, Prof, Pocock, Stuart J, Prof, Dangas, George, Prof, Wong, S Chiu, MD, Fahy, Martin, MSc, Parise, Helen, ScD, Mehran, Roxana, Prof

“…Summary Background Primary results of the HORIZONS-AMI trial have been previously reported. In this final report, we aimed to assess 3-year outcomes. Methods…”
Get full text

European Association for Endoscopic Surgery (EAES) consensus on Indocyanine Green (ICG) fluorescence-guided surgery by Cassinotti, E., Al-Taher, M., Antoniou, S. A., Arezzo, A., Baldari, L., Boni, L., Bonino, M. A., Bouvy, N. D., Brodie, R., Carus, T., Chand, M., Diana, M., Eussen, M. M. M., Francis, N., Guida, A., Gontero, P., Haney, C. M., Jansen, M., Mintz, Y., Morales-Conde, S., Muller-Stich, B. P., Nakajima, K., Nickel, F., Oderda, M., Parise, P., Rosati, R., Schijven, M. P., Silecchia, G., Soares, A. S., Urakawa, S., Vettoretto, N.

“…Background In recent years, the use of Indocyanine Green (ICG) fluorescence-guided surgery during open and laparoscopic procedures has exponentially expanded…”
Get full text

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial by Mehran, Roxana, Dr, Lansky, Alexandra J, MD, Witzenbichler, Bernhard, MD, Guagliumi, Giulio, MD, Peruga, Jan Z, MD, Brodie, Bruce R, MD, Dudek, Dariusz, MD, Kornowski, Ran, MD, Hartmann, Franz, MD, Gersh, Bernard J, Prof, Pocock, Stuart J, Prof, Wong, S Chiu, MD, Nikolsky, Eugenia, MD, Gambone, Louise, MD, Vandertie, Lynn, Parise, Helen, ScD, Dangas, George D, MD, Stone, Gregg W, Prof

“…Summary Background In the HORIZONS-AMI trial, patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary…”
Get full text

Imaging‐based predictors of permanent pacemaker implantation after transcatheter aortic valve replacement by Routh, Jared M., Joseph, Lee, Marthaler, Brodie R., Bhave, Prashant D.

“…Background Cardiac conduction abnormalities requiring permanent pacemaker (PPM) implantation are major complications of transcatheter aortic valve replacement…”
Get full text

Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study) by Redfors, Björn, Chen, Shmuel, Ben-Yehuda, Ori, Huang, Xin, Witzenbichler, Bernhard, Weisz, Giora, Liu, Yangbo, Brodie, Bruce R., Rinaldi, Michael J., Neumann, Franz-Josef, Metzger, D. Christopher, Henry, Timothy D., Cox, David A., Duffy, Peter L., Mazzaferri, Ernest L., Mehran, Roxana, Stuckey, Thomas D., Kirtane, Ajay J., Stone, Gregg W.

“…Hypertension is associated with vascular and endothelial dysfunction that may result in a greater propensity for reactive platelets to cause thrombosis. We…”
Get full text

Cardiobacterium hominis endocarditis incidentally diagnosed following an aortic valve replacement surgery by Radovanovic, Milan, Marthaler, Brodie R., Nordstrom, Charles W., Petrovic, Marija, Dumic, Igor, Barsoum, Michel K.

“…Cardiobacterum hominis (C. hominis) is the part of the HACEK group (Haemophilus spp, Actinobacillus spp, C. hominis, Eikenella, and Kingella spp) that accounts…”
Get full text

DNA intercalators in cancer therapy: organic and inorganic drugs and their spectroscopic tools of analysis by Wheate, Nial J, Brodie, Craig R, Collins, J Grant, Kemp, Sharon, Aldrich-Wright, Janice R

“…Since the discovery of the DNA intercalation process by Lerman in 1961 thousands of organic, inorganic octahedral (particularly ruthenium(II) and rhodium(III))…”
Get more information

Clinical Outcomes Following Stent Thrombosis Occurring In-Hospital Versus Out-of-Hospital by Dangas, George D., MD, PhD, Claessen, Bimmer E., MD, PhD, Mehran, Roxana, MD, Brener, Sorin, MD, Brodie, Bruce R., MD, Dudek, Dariusz, MD, Witzenbichler, Bernhard, MD, Peruga, Jan Z., MD, Guagliumi, Giulio, MD, PhD, Moses, Jeffrey W., MD, Lansky, Alexandra J., MD, Xu, Ke, PhD, Stone, Gregg W., MD

“…Objectives The study sought to determine whether rapid access to medical care and reperfusion results in a better prognosis in patients with in-hospital…”
Get full text

Comparison of Plaque Characteristics in Narrowings With ST-Elevation Myocardial Infarction (STEMI), Non-STEMI/Unstable Angina Pectoris and Stable Coronary Artery Disease (from the ADAPT-DES IVUS Substudy) by Dong, Liang, MD, Mintz, Gary S., MD, Witzenbichler, Bernhard, MD, Metzger, D. Christopher, MD, Rinaldi, Michael J., MD, Duffy, Peter L., MD, Weisz, Giora, MD, Stuckey, Thomas D., MD, Brodie, Bruce R., MD, Yun, Kyeong Ho, MD, Xu, Ke, PhD, Kirtane, Ajay J., MD, SM, Stone, Gregg W., MD, Maehara, Akiko, MD

“…Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) was a prospective, multicenter registry of 8,582 consecutive stable and unstable…”
Get full text

Long-Term Prognosis of Patients Presenting With ST-Segment Elevation Myocardial Infarction With No Significant Coronary Artery Disease (from The HORIZONS-AMI Trial) by Larsen, Alf Inge, MD, PhD, Nilsen, Dennis W.T., MD, PhD, Yu, Jennifer, MD, Mehran, Roxana, MD, Nikolsky, Eugenia, MD, PhD, Lansky, Alexandra J., MD, Caixeta, Adriano, MD, PhD, Parise, Helen, ScD, Fahy, Martin, MSc, Cristea, Ecaterina, MD, Witzenbichler, Bernhard, MD, Guagliumi, Giulio, MD, Peruga, Jan Z., MD, Brodie, Bruce R., MD, Dudek, Dariusz, MD, PhD, Stone, Gregg W., MD

“…The clinical features and prognosis of patients with ST-segment elevation myocardial infarction (STEMI) and no significant coronary artery disease (CAD) have…”
Get full text

Benefit of Facilitated Percutaneous Coronary Intervention in High-Risk ST-Segment Elevation Myocardial Infarction Patients Presenting to Nonpercutaneous Coronary Intervention Hospitals by Herrmann, Howard C., MD, Lu, Jiandong, MD, Brodie, Bruce R., MD, Armstrong, Paul W., MD, Montalescot, Gilles, MD, PhD, Betriu, Amadeo, MD, Neuman, Franz-Joseph, MD, Effron, Mark B., MD, Barnathan, Elliot S., MD, Topol, Eric J., MD, Ellis, Stephen G., MD

“…Objectives We hypothesized that patients most likely to benefit would be those at high risk with a shorter duration of acute ischemia and who required transfer…”
Get full text

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study by Stuckey, Thomas D, Kirtane, Ajay J, Brodie, Bruce R, Witzenbichler, Bernhard, Litherland, Claire, Weisz, Giora, Rinaldi, Michael J, Neumann, Franz-Josef, Metzger, D Christopher, Henry, Timothy D, Cox, David A, Duffy, Peter L, Mazzaferri, Jr, Ernest L, Gurbel, Paul A, Mehran, Roxana, Généreux, Philippe, Ben-Yehuda, Ori, Simonton, Charles A, Stone, Gregg W

“…In this analysis of 2-year outcomes in the ADAPT-DES (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents) study, the authors sought to examine…”
Get full text